Aaron R Mangold

16PUBLICATIONS
92CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMedical devicesPharmacogenomicsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris.

Alyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu

|Oct 07, 2025
Recurrent status is associated with poor outcomes in cutaneous squamous cell carcinoma.

Cristian Cardona-Machado, Nina A Ran, Emily E Granger

|Feb 15, 2025
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis.

Nicolas Coudray, Michelle C Juarez, Maressa C Criscito

|Feb 14, 2025
Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus.

Nan Zhang, Alyssa L Stockard, Zachary Leibovit-Reiben

|Jul 03, 2024
Targeting IL-1 controls refractory pityriasis rubra pilaris.

Eloi Schmauch, Yannik Severin, Xianying Xing

|Jan 23, 2024
Oral Baricitinib in the Treatment of Cutaneous Lichen Planus.

Angelina Hwang, Jacob Kechter, Tran Do

Pageof 3